Mor-NuCo Enterprises, Inc.
Records under this name other than patents Mor-NuCo Enterprises, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Mor-NuCo Enterprises, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,891,222 | Methods and compositions for identification and quantification of ENOX2 transcript variants as indications of cancer presence in blood serum and other body fluids based on gold or silver nanoparticle formation Lapsed on the fee record Ended Feb 13, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 13, 2026 | From the USPTO record |
| US 9,804,165 | Methods and compositions for targeted two-dimensional western blot analysis for early cancer detection and cancer diagnosis up to ten years in advance of clinical symptoms of malignant disease Lapsed on the fee record Ended Oct 31, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 31, 2025 | From the USPTO record |
| US 9,804,166 | Methods for single chain variable region ENOX2 antibodies for cancer detection and diagnosis Lapsed on the fee record Ended Oct 31, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 31, 2025 | From the USPTO record |
| US 9,739,782 | Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis Lapsed on the fee record Ended Aug 22, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 22, 2025 | From the USPTO record |
| US 9,612,243 | Methods and compositions for targeted two-dimensional western blot analysis for early cancer detection and cancer diagnosis up to ten years in advance of clinical symptoms of malignant disease Lapsed on the fee record Ended Apr 4, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 4, 2025 | From the USPTO record |
| US 9,459,256 | Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis Lapsed on the fee record Ended Oct 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2024 | From the USPTO record |
| US 10,712,345 | Methods and compositions for single chain variable region ENOX2 antibodies for cancer detection and diagnosis Lapsed on the fee record Ended Jul 14, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 14, 2024 | From the USPTO record |